SJG-136
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SJG-136, covering 2013-09-30 to 2015-05-25. Get the full timeline:
Most recent: Clinical Trial Update: SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin [Phase 2]